Get started
Author

Ken Maes

Observed names: K Maes, K. Maes, Maes, Ken
ORCID: 0000-0001-8906-2790
Observed ORCID: 0000-0001-8906-2790
OpenAlex ID: A5091159768
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
2018 · Sylvia Faict, Joséphine Muller, et al. · Blood Cancer Journal · 156
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
2015 · Jinheng Wang, Kim De Veirman, et al. · Oncotarget · 155
PDF
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
2016 · Kim De Veirman, Jinheng Wang, et al. · Cancer Letters · 142
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2
2010 · Ken Maes, Elizabeta Nemeth, et al. · Blood · 136
Novel strategies to target the ubiquitin proteasome system in multiple myeloma
2015 · Susanne Lub, Ken Maes, et al. · Oncotarget · 86
PDF
Metabolic Features of Multiple Myeloma
2018 · Chaima El Arfani, Kim De Veirman, et al. · International Journal of Molecular Sciences · 76
PDF
Tumour‐associated macrophage‐mediated survival of myeloma cells through STAT3 activation
2016 · Nathan De Beule, Kim De Veirman, et al. · The Journal of Pathology · 69
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
2016 · Jinheng Wang, Sylvia Faict, et al. · Oncotarget · 67
PDF
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma
2014 · Ken Maes, Eva De Smedt, et al. · Oncotarget · 65
PDF
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
2020 · Yana Dekempeneer, Vicky Caveliers, et al. · Molecular Pharmaceutics · 62
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
2018 · Eva De Smedt, Hui Lui, et al. · Frontiers in Oncology · 62
PDF
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
2016 · Liesbeth Bieghs, Hans E. Johnsen, et al. · Oncotarget · 62
PDF
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
2018 · Kim De Veirman, Eline Menu, et al. · Cancer Letters · 60
The therapeutic potential of cell cycle targeting in multiple myeloma
2017 · Anke Maes, Eline Menu, et al. · Oncotarget · 59
PDF
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
2017 · Kim De Veirman, Nathan De Beule, et al. · Cancer Immunology Research · 57
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
2013 · Ken Maes, Eline Menu, et al. · Cancers · 56
PDF
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma
2019 · Sylvia Faict, Inge Oudaert, et al. · Cancers · 55
PDF
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells
2015 · Susanne Lub, Anke Maes, et al. · Oncotarget · 53
PDF
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
2018 · Angelique Bruyer, Ken Maes, et al. · British Journal of Cancer · 48
PDF
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression
2017 · Eva De Smedt, Ken Maes, et al. · Cancer Research · 43
PDF
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
2017 · Mérédis Favreau, Koen Venken, et al. · Haematologica · 43
PDF
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
2021 · Eva De Smedt, Julie Devin, et al. · Blood Advances · 35
Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma
2017 · M Favreau, E Menu, et al. · Leukemia · 34
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
2023 · Rong Fan, Hatice Satilmis, et al. · Journal for ImmunoTherapy of Cancer · 33
PDF
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
2019 · Siyang Yan, Niels Vandewalle, et al. · Cancers · 33
PDF
Works count: 108
Citation count: 2,104
H-index: 28
I10-index: 40
Year
Topic
Type